-
Trade Name
MenQuadfi
Solution for injection
Request Type
Registration
Drug Type
Generic Drug
Approval Date
SFDA Approved Use
MenQuadfi is indicated for active immunization of individuals from the age of 12 months and older against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y.